The Visual Matrix: The case of Mimar Sinan Project Site Bilkent University, Turkeyhttp://www.art.bilkent.edu.tr/iaed Abstract. This paper introduces a web-based ‘visual reference system’ model for archi-tectural education and research. The system utilizes visualization to aid in spatial com-prehension and comparative analysis of abstract architectural concepts. The systemestablishes a
sydneyrx2014.com Online ED Pharmacy is an 1st. pharmacy providing a personal service to the community in Australia. Over 50,000 extremely satisfied customers! We're your prescription drug store cialis australia and have provided trusted service to families in Australia for over 15 years.
The lpg cellu m6 keymodule gets fda clearance for treating lymphedema - free-press-release.comThe LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema - Free-Press-Release.com The LPG Cellu M6 Keymodule Gets FDA Clearance for
The FDA has just given the Class 1 Cellu M6 Keymodule, manufactured by LPG, Inc. (the
world leader in connective tissue technology), full FDA clearance for treating Lymphedema.
Miami, FL – According to the World Health Organization, Lymphedema afflicts hundreds of millions worldwide. Of 47% Reduction in Cellulite in Just 9 Minutes! See these, the US Department of Health and Human Services estimates more than 300 million are American. Variousforms of massage are used to treat this painful condition, but none really have enough consistency or depth-of- action to produce results. But now one does. The Food and Vetenskapligt bevisat resultat! LPG-Endermologie Drug Administration (FDA), has just given the Class 1 Cellu M6 Keymodule, manufactured by LPG, Inc. (a medical device company renowned as the world leader in connective tissue technology), full FDA clearance for Localized Hardening of Your Parts Lower Cost Lymphedema. The new claims are as follows: • Reduction of secondary Lymphedema of the arm (SLA) post mastectomy (RX only)• Improvement of secondary Lymphedema (RX only) • Improvement of lymphatic circulation in the treated area (RX only) For this FDA clearance, LPG presented well-documented, scientifically proven clinical results showing the Technology’s efficacy on the body’s circulatory, anti-edematous and dermatrophic systems. Along with these published studies, multimodal clinical studies examining the efficacy and durability of the traditional ManualLymphatic Drainage (MLD) and Compression Bandaging (CB) versus the non-invasive LPG Treatment were conducted by Neil Piller, M.D., Professor for Lymphology at the Lymphedema Assessment Clinic of Flinders University Medical Center in South Australia. Michel Van Welden, the Chief Executive Officer of Techno-Derm (LPG’s exclusive US distributor), explains, "Dr.
Piller’s research demonstrates that LPG Technology offers an all-inclusive, standardized therapy for SLA pathology –with greater consistency, efficacy and faster results than MLD – which confirms that LPG devices are essential for The research concluded that the LPG Treatment showed significant decreases in perometry (18%), bio-impedance (23.5%), and tissue softening in half the time as the MLD control group and with a sustained effect. What’s that mean? That LPG’s FDA cleared Cellu M6 Keymodule presents a lastingly effective solution for millions ofLymphedema sufferers around the world. Lymphedema occurs whenever lymph nodes have been damaged - so although this study examines the Cellu M6 Keymodule’s treatment of mastectomy Lymphedema – it’s also ideal for Lymphedemas resulting from lumpectomies, radiation treatments and many other procedures. Company Information:LPG Technology is marketed and distributed by Techno-Derm, LLC, (DBA: LPG America), 10800 Biscayne Blvd., Ste. 850 in Miami, Florida. For more on LPG treatments and LPG’s FDA-cleared , visit To view a copy of Piller’s study, learn more about LPG’s FDA Lymphedema claims or schedule an interview with a http://www.free-press-release.com/news/200812/1229457538.html The LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema - Free-Press-Release.com To view a copy of Piller’s study, learn more about LPG’s FDA Lymphedema claims or schedule an interview with aCompany representative, please contact Rebecca Hausen at 305-335-8696 or by email firstname.lastname@example.org. For more information:
3500 Coral Way, Ste. 1002 Miami, FL 33145 Representing www.cellum6.com l ted Artic
Link to this: http://www.free-press-release.com/news/200812/1229457538.html L ave a Com
p ess rele
p ess rele
All press release information on this site, including free press release and premier press release, is solely based on what our users submit. Free-Press-Release.com http://www.free-press-release.com/news/200812/1229457538.html The LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema - Free-Press-Release.com disclaims that any right and,is solely based on what our users submit. Free- Press-Release.com disclaims that any right and responsibility for the information go to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider withany questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and http://www.free-press-release.com/news/200812/1229457538.html
Effect of Efavirenz on the Pharmacokinetics of Ethinyl Estradiol and Norgestimate in Healthy Female Subjects H. Sevinsky, T. Eley, B. He, A. Persson, D. Garner, C. Yones, R. Nettles, R. Bertz and J. Zhang Bristol-Myers Squibb Research and Development, Princeton, NJ USA Introducti Introducti on Results (Cont’d) Results (Cont’d) Results (Cont’d) Efavirenz (EFV) is